Yiheng Capital Management, L.P. Crispr Therapeutics Ag Transaction History
Yiheng Capital Management, L.P.
- $2.46 Billion
- Q4 2024
A detailed history of Yiheng Capital Management, L.P. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Yiheng Capital Management, L.P. holds 6,300 shares of CRSP stock, worth $334,026. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,300Holding current value
$334,026% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CRSP
# of Institutions
484Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$476 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$464 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$202 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$147 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$146 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.14B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....